We concluded that BCPs treatment could ameliorate hepatic steatosis via the PPARα/CPT1 pathway in HFD-induced obese rats.Moreover, the degradation of DAG occurs through the phosphorylation and cytidine diphosphate diacylglycerol (CDP-DAG) pathway by DGK and EPT1, generating PA and PE, respectively (50, 51). The gene discussed is CPT1A; the disease is Hepatic steatosis.